Pandion Therapeutics Highlights Prospective of Modular Biologics Pipeline for the Cure of Autoimmune Illnesses at FOCIS 2020
WATERTOWN, Mass., Oct. 28, 2020 (Globe NEWSWIRE) -- Pandion Therapeutics, Inc. (Nasdaq: PAND), a clinical-stage biotechnology corporation building novel therapeutics...
